UPDATE : Monday, September 7, 2020
Samsung Biologics makes CDO partnership with Taiwanese bio-venture
Samsung Biologics said that it has entered into a contract developing organ...
by Lee Han-soo  |  2020-03-17 17:31
Celltrion Healthcare launches anticancer biosimilar Herzuma in US
Celltrion Healthcare said Tuesday that the company has launched its antican...
by Lee Han-soo  |  2020-03-17 16:21
‘Celltrion to invest ₩20 billion to develop COVID-19 cure in 6 months’
Celltrion said that it would start clinical trials on humans to come up wit...
by Lee Han-soo  |  2020-03-13 17:38
SK Bioscience threatens MSD's sway over shingles vaccine market
SK Bioscience's shingles vaccine Skyzoster, launched only two years ago...
by Lee Han-soo  |  2020-03-12 17:05
Bridge Biotherapeutics, Atomwise to develop new drugs using AI
Bridge Biotherapeutics said that it would partner up with Atomwise, a U.S. ...
by Lee Han-soo  |  2020-03-10 12:26
Celltrion applies for approval of new Humira biosimilar to EMA
Celltrion said Monday that it has completed the application of its CT-P17, ...
by Shim Hyun-tai  |  2020-03-09 16:40
Celltrion Healthcare’s 2019 sales top ₩1 trillion
Celltrion Healthcare said that it registered 1 trillion won ($840.6 million...
by Lee Han-soo  |  2020-03-06 17:31
Samsung BioLogics, STCube to develop immunotherapies
Samsung BioLogics said that it has signed a contract development organizati...
by Lee Han-soo  |  2020-03-03 16:18
Celltrion Healthcare presents Remsima SC in UK
Celltrion Healthcare, the distribution and marketing unit of Korea's bi...
by Lee Han-soo  |  2020-03-02 17:42
HLB seeks new pipelines by taking over US biotech firm
HLB, a Kosdaq-listed firm, said it would seek to secure new pipelines other...
by Jeong Sae-im  |  2020-02-21 15:42
Celltrion’s annual revenue surpassed ₩1 trillion in 2019
Celltrion, the nation’s leading biosimilar manufacturer, said its annual sa...
by Jeong Sae-im  |  2020-02-20 15:47
Prescription of Celltrion’s Remsima SC started in Germany
Celltrion Healthcare, the distribution and marketing unit of Korea’s biosim...
by Jeong Sae-im  |  2020-02-18 16:05
Korea University analyzes 5,000 cancer patients’ genomic data 
Korea University’s state-supported precision medicine project group, dubbed...
by Kim Yun-mi  |  2020-02-11 15:49
Sillajen's loss more than doubles due to Pexa-Vec trial failure
Sillajen’s losses more than doubled last year as the company failed its pha...
by Jeong Sae-im  |  2020-02-03 16:08
Kolon CEO arrested for mislabeling Invossa’s ingredient
A local court issued an arrest warrant for Kolon Life Science CEO Lee Woo-s...
by Jeong Sae-im  |  2020-02-03 15:34
Interpark embarks on organoid business
“We will develop organoid-based new medicines and realize customized precis...
by Park Gi-taek  |  2020-01-27 11:18
Samsung BioLogics’ annual sales up 30% on contract research growth
Samsung BioLogics saw its earnings surge last year, as it pursued more cont...
by Jeong Sae-im  |  2020-01-23 14:47
Celltrion Group to build biopharmaceutical plant in China
Celltrion Group said that it plans to build a biopharmaceutical factory in ...
by Lee Han-soo  |  2020-01-21 18:00
Korea’s biopharma power shines at JP Morgan Healthcare meet
Korean pharmaceutical and biotech companies showed off their technological ...
by Jeong Sae-im  |  2020-01-17 15:20
HLB stocks fall in after-hours trading due to interview on rivoceranib
HLB, a Kosdaq-listed firm, said it would introduce new anticancer pipelines...
by Jeong Sae-im  |  2020-01-16 15:46
Back to Top